These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 22118699

  • 1. Des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma and liver cirrhosis.
    Inagaki Y, Xu HL, Hasegawa K, Aoki T, Beck Y, Sugawara Y, Tang W, Kokudo N.
    J Dig Dis; 2011 Dec; 12(6):481-8. PubMed ID: 22118699
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of des-gamma-carboxyprothrombin expression in hepatocellular carcinoma.
    Harino Y, Fujii M, Imura S, Morine Y, Ikemoto T, Soejima Y, Shimada M.
    Hepatogastroenterology; 2008 Dec; 55(85):1385-9. PubMed ID: 18795695
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin.
    Inagaki Y, Tang W, Makuuchi M, Hasegawa K, Sugawara Y, Kokudo N.
    Liver Int; 2011 Jan; 31(1):22-35. PubMed ID: 20874725
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Des-gamma-carboxy prothrombin (DCP) ratio is a useful prognostic tumor marker for single nodule hepatocellular carcinoma (HCC).
    Murakami N, Tamano M, Yoneda M, Sugaya H, Hiraishi H.
    Hepatogastroenterology; 2008 Jan; 55(81):197-201. PubMed ID: 18507106
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Des-γ-carboxyprothrombin (DCP) and NX-DCP expressions and their relationship with clinicopathological features in hepatocellular carcinoma.
    Sumi A, Akiba J, Ogasawara S, Nakayama M, Nomura Y, Yasumoto M, Sanada S, Nakashima O, Abe T, Yano H.
    PLoS One; 2015 Jan; 10(3):e0118452. PubMed ID: 25739032
    [Abstract] [Full Text] [Related]

  • 13. Measurement of des-gamma-carboxy prothrombin levels in cancer and non-cancer tissue in patients with hepatocellular carcinoma.
    Yuan LW, Tang W, Kokudo N, Sugawara Y, Karako H, Hasegawa K, Aoki T, Kyoden Y, Deli G, Li YG, Makuuchi M.
    Oncol Rep; 2004 Aug; 12(2):269-73. PubMed ID: 15254687
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma.
    Nagaoka S, Yatsuhashi H, Hamada H, Yano K, Matsumoto T, Daikoku M, Arisawa K, Ishibashi H, Koga M, Sata M, Yano M.
    Cancer; 2003 Dec 15; 98(12):2671-7. PubMed ID: 14669288
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
    Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Takasaki K, Takenami K, Yamamoto M, Nakano M.
    Cancer; 2000 Feb 01; 88(3):544-9. PubMed ID: 10649245
    [Abstract] [Full Text] [Related]

  • 18. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.
    Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Watanabe K, Magario N, Yokoo T, Naraki T.
    Cancer; 1999 Feb 15; 85(4):812-8. PubMed ID: 10091758
    [Abstract] [Full Text] [Related]

  • 19. Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma.
    Matsubara M, Shiraha H, Kataoka J, Iwamuro M, Horiguchi S, Nishina S, Takaoka N, Uemura M, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yamamoto K.
    J Gastroenterol Hepatol; 2012 Oct 15; 27(10):1602-8. PubMed ID: 22554292
    [Abstract] [Full Text] [Related]

  • 20. Vitamin K2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin.
    Ma M, Qu XJ, Mu GY, Chen MH, Cheng YN, Kokudo N, Tang W, Cui SX.
    Chemotherapy; 2009 Oct 15; 55(1):28-35. PubMed ID: 18974646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.